Member Info for JohnHenry

Positive news from Itumbula and HE1 will be able to get the next round of funding to deepen TAI3

Aimho

After reading Nobles presentation i am more positive towards HE1

If Noble can prove up their pilot depressuring study then boom.

Its fair value, as at these prices its a hero or zero punt.

Itumbula failure and the company is toast.

HVB $225 down 5

Https://www.youtube.com/watch?v=yse17sDbDF8

Wimbledon imho Blaisse obsession to drill and complete Phase 2 has lead to the eventual collapse of the company.

Imho Sarah Cope and the broker are responsible for the 0.25p placing.

Minchen and HE1 licenced S Rukwa however it would appear N Rukwa ( Noble Helium) is the sweet spot for a commercial find.

Noble Helium also ran 3d seismic as to HE1 2d

RCMPMounties ive listened to every presentation delivered by HE1 over the past 5 years many times. Read every RNS many times.

Conclusion TAI was the flagship that failed.

If they do wimbledon 2 -2.5p,

I have no doubt they will find fairly high concentrations of Helium.

Unfortunately i dont think they will have an effective seal for a commercial development.

If Itumbula fails to support a commercial discovery the Blaisse will certainly walk.

Its been her dogmatic attitude to buy a cold stored rig when they are still an exploration company and hence the collapse of the company.

She talked about using the rig in the future a little premature when you have no commercial discovery.

Maybe Noble Helium will offer a few million for the licence and rig.

North Rukwa is the sweet spot.

At Mbelele far far exceeded the results at TAI

Unfortunately in hindsight Minchen Licensed the wrong area.

As ive been saying Skippy NH found an effective seal with trapped free gas.

HE1 didnt find any trapped free gas because there was no effective seal.

TAI was HE1 primary target for a possible seal. No seal.

Itumbula will discover Helium but it wont be trapped hence non commercial

Aimho

If you listen to all the Youtube Presentations, one common theme is TAI is there their prime area for finding trapped free gas.

Unfortunately they found no effective seal or trapped free gas at TAI

The area is full of faults and fractures, hence a distinct possibility that no free gas is trapped hence non commercial.

Establishing reimbursement coverage and payment

The new reimbursement APC-code (C9791) issued by the US Centers for Medicare & Medicaid Services ("CMS") in August 2023 for the XENOVIEW MRI technology corresponds to a payment range of between US$1,201 to US$1,300.

The new code, along with additional existing codes for the XENOVIEW MRI process, enables the hospitals to request a total reimbursement of approximately $2,500, representing a significantly improved economic incentive for the hospital. All seven United States Medicare Administrative Contractors (MACs), who are responsible for processing Medicare claims, are covering the code as of 1 October 2023 based on medical necessity.

Building on the new code from CMS, work is beginning at Polarean's clinical sites to further expand the reimbursement for private U.S. health insurers to enable further utilisation of XENOVIEW.

The sell was probably placed into the market weeks ago and has been worked in the market until complete, then stamped.

Its a completed worked sell probably runs back to the 7th and 8th December

Fair enough Skippy 3 months working capital and the lights go out

Issue with Blaisse and the BOD is they act as if theres a never ending shareholder funding tree.

Theyve treated shareholder funds with complete contempt.

They have wasted millions.

Im afraid Itumbula is last chance saloon.